{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:37:10Z","timestamp":1788910630647,"version":"build-2803163510"},"reference-count":265,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014584","name":"Universit\u00e4tsmedizin der Johannes Gutenberg-Universit\u00e4t Mainz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014584","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pflugers Arch - Eur J Physiol"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hypertensive disorders of pregnancy are complications that can lead to maternal and infant mortality and morbidity. Hypertensive disorders of pregnancy are generally defined as hypertension and may be accompanied by other end organ damages including proteinuria, maternal organ disturbances including renal insufficiency, neurological complications, thrombocytopenia, impaired liver function, or uteroplacental dysfunction such as fetal growth restriction and stillbirth. Although the causes of these hypertensive disorders of pregnancy are multifactorial and elusive, they seem to share some common vascular-related mechanisms, including diseased spiral arteries, placental ischemia, and endothelial dysfunction. Recently, preeclampsia is being considered as a vascular disorder. Unfortunately, due to the complex etiology of preeclampsia and safety concerns on drug usage during pregnancy, there is still no effective pharmacological treatments available for preeclampsia yet. An emerging area of interest in this research field is the potential beneficial effects of dietary intervention on reducing the risk of preeclampsia. Recent studies have been focused on the association between deficiencies or excesses of some nutrients and complications during pregnancy, fetal growth and development, and later risk of cardiovascular and metabolic diseases in the offspring. In this review, we discuss the involvement of placental vascular dysfunction in preeclampsia. We summarize the current understanding of the association between abnormal placentation and preeclampsia in a vascular perspective. Finally, we evaluate several studied dietary supplementations to prevent and reduce the risk of preeclampsia, targeting placental vascular development and function, leading to improved pregnancy and postnatal outcomes.<\/jats:p>","DOI":"10.1007\/s00424-023-02810-2","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T15:03:17Z","timestamp":1681311797000},"page":"889-905","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Dietary supplements and vascular function in hypertensive disorders of pregnancy"],"prefix":"10.1007","volume":"475","author":[{"given":"Andy W C","family":"Man","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huige","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"key":"2810_CR1","unstructured":"World Health Organization. Fact sheet - maternal mortality. Available at: https:\/\/www.who.int\/news-room\/factsheets\/detail\/maternalmortality#:~:text=A%20woman's%20lifetime%20risk%20of,49%20in%20low%2Dincome%20countries"},{"issue":"6","key":"2810_CR2","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","volume":"2","author":"L Say","year":"2014","unstructured":"Say L et al (2014) Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health 2(6):e323\u2013e333","journal-title":"Lancet Glob Health"},{"issue":"1","key":"2810_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","volume":"72","author":"MA Brown","year":"2018","unstructured":"Brown MA et al (2018) Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension 72(1):24\u201343","journal-title":"Hypertension"},{"key":"2810_CR4","volume-title":"Williams obstetrics, 24e","author":"FG Cunningham","year":"2014","unstructured":"Cunningham FG et al (2014) Williams obstetrics, 24e. Mcgraw-Hill New York, NY USA"},{"issue":"10022","key":"2810_CR5","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","volume":"387","author":"BWJ Mol","year":"2016","unstructured":"Mol BWJ et al (2016) Pre-eclampsia. Lancet 387(10022):999\u20131011","journal-title":"Lancet"},{"issue":"1","key":"2810_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/epirev\/mxt006","volume":"36","author":"JW Rich-Edwards","year":"2014","unstructured":"Rich-Edwards JW et al (2014) Pregnancy characteristics and women\u2019s future cardiovascular health: an underused opportunity to improve women\u2019s health? Epidemiol Rev 36(1):57\u201370","journal-title":"Epidemiol Rev"},{"issue":"4","key":"2810_CR7","doi-asserted-by":"publisher","first-page":"e1001425","DOI":"10.1371\/journal.pmed.1001425","volume":"10","author":"DS Feig","year":"2013","unstructured":"Feig DS et al (2013) Preeclampsia as a risk factor for diabetes: a population-based cohort study. PLoS Med 10(4):e1001425","journal-title":"PLoS Med"},{"issue":"7323","key":"2810_CR8","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1136\/bmj.323.7323.1213","volume":"323","author":"HU Irgens","year":"2001","unstructured":"Irgens HU et al (2001) Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 323(7323):1213\u20131217","journal-title":"BMJ"},{"issue":"9499","key":"2810_CR9","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/S0140-6736(05)67726-4","volume":"366","author":"JG Ray","year":"2005","unstructured":"Ray JG et al (2005) Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 366(9499):1797\u20131803","journal-title":"Lancet"},{"issue":"2","key":"2810_CR10","doi-asserted-by":"publisher","first-page":"H541","DOI":"10.1152\/ajpheart.01113.2007","volume":"294","author":"JS Gilbert","year":"2008","unstructured":"Gilbert JS et al (2008) Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol 294(2):H541\u2013H550","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2810_CR11","doi-asserted-by":"publisher","first-page":"g1446","DOI":"10.1136\/bmj.g1446","volume":"348","author":"L Englund-Ogge","year":"2014","unstructured":"Englund-Ogge L et al (2014) Maternal dietary patterns and preterm delivery: results from large prospective cohort study. Bmj 348:g1446","journal-title":"Bmj"},{"issue":"6","key":"2810_CR12","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.3945\/jn.109.104968","volume":"139","author":"AL Brantsaeter","year":"2009","unstructured":"Brantsaeter AL et al (2009) A dietary pattern characterized by high intake of vegetables, fruits, and vegetable oils is associated with reduced risk of preeclampsia in nulliparous pregnant Norwegian women. J Nutr 139(6):1162\u20131168","journal-title":"J Nutr"},{"key":"2810_CR13","first-page":"1","volume":"22","author":"KT Kibret","year":"2018","unstructured":"Kibret KT et al (2018) Maternal dietary patterns and risk of adverse pregnancy (hypertensive disorders of pregnancy and gestational diabetes mellitus) and birth (preterm birth and low birth weight) outcomes: a systematic review and meta-analysis. Public Health Nutr 22:1\u201315","journal-title":"Public Health Nutr"},{"issue":"4","key":"2810_CR14","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.ajog.2005.10.813","volume":"194","author":"J Villar","year":"2006","unstructured":"Villar J et al (2006) Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am J Obstet Gynecol 194(4):921\u2013931","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2810_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1067\/mob.2002.120080","volume":"186","author":"A Buchbinder","year":"2002","unstructured":"Buchbinder A et al (2002) Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol 186(1):66\u201371","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"2810_CR16","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1471-0528.2003.02162.x","volume":"110","author":"H Strevens","year":"2003","unstructured":"Strevens H et al (2003) Glomerular endotheliosis in normal pregnancy and pre-eclampsia. BJOG 110(9):831\u2013836","journal-title":"BJOG"},{"issue":"5","key":"2810_CR17","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.cjca.2018.02.021","volume":"34","author":"S Butalia","year":"2018","unstructured":"Butalia S et al (2018) Hypertension Canada\u2019s 2018 guidelines for the management of hypertension in pregnancy. Can J Cardiol 34(5):526\u2013531","journal-title":"Can J Cardiol"},{"issue":"7","key":"2810_CR18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1701-2163(15)30533-8","volume":"36","author":"LA Magee","year":"2014","unstructured":"Magee LA et al (2014) Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can 36(7):575\u2013576","journal-title":"J Obstet Gynaecol Can"},{"issue":"1","key":"2810_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/ajo.12253","volume":"55","author":"SA Lowe","year":"2015","unstructured":"Lowe SA et al (2015) The SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014. Aust N Z J Obstet Gynaecol 55(1):11\u201316","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"5","key":"2810_CR20","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/01.AOG.0000437382.03963.88","volume":"122","author":"American College of Obstetricians and Gynecologists","year":"2013","unstructured":"American College of Obstetricians and Gynecologists (2013) Task force on hypertension in pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 task force on hypertension in pregnancy. Obstet Gynecol 122(5):1122\u20131131","journal-title":"Obstet Gynecol"},{"key":"2810_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijgo.12802","volume":"145","author":"LC Poon","year":"2019","unstructured":"Poon LC et al (2019) The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet 145:1\u201333","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"2810_CR22","first-page":"121","volume":"93","author":"L Leeman","year":"2016","unstructured":"Leeman L, Dresang LT, Fontaine P (2016) Hypertensive disorders of pregnancy. Am Fam Physician 93(2):121\u2013127","journal-title":"Am Fam Physician"},{"issue":"2","key":"2810_CR23","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0002-9378(00)70216-X","volume":"182","author":"F Mattar","year":"2000","unstructured":"Mattar F, Sibai BM, Eclampsia VIII (2000) Risk factors for maternal morbidity. Am J Obstet Gynecol 182(2):307\u2013312","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2810_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/01.AOG.0000152351.13671.99","volume":"105","author":"BM Sibai","year":"2005","unstructured":"Sibai BM (2005) Diagnosis, prevention, and management of eclampsia. Obstet Gynecol 105(2):402\u2013410","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2810_CR25","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1097\/AOG.0000000000003508","volume":"134","author":"EK Redman","year":"2019","unstructured":"Redman EK et al (2019) Clinical course, associated factors, and blood pressure profile of delayed-onset postpartum preeclampsia. Obstet Gynecol 134(5):995\u20131001","journal-title":"Obstet Gynecol"},{"issue":"7398","key":"2810_CR26","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11040","volume":"485","author":"IS Patten","year":"2012","unstructured":"Patten IS et al (2012) Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 485(7398):333\u2013338","journal-title":"Nature"},{"issue":"2","key":"2810_CR27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1586\/14779072.5.2.283","volume":"5","author":"J Newstead","year":"2007","unstructured":"Newstead J, von Dadelszen P, Magee LA (2007) Preeclampsia and future cardiovascular risk. Expert Rev Cardiovasc Ther 5(2):283\u2013294","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"4","key":"2810_CR28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1042\/CS20150567","volume":"130","author":"ND Paauw","year":"2016","unstructured":"Paauw ND et al (2016) Long-term renal and cardiovascular risk after preeclampsia: towards screening and prevention. Clin Sci (Lond) 130(4):239\u2013246","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"2810_CR29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","volume":"33","author":"L Duley","year":"2009","unstructured":"Duley L (2009) The global impact of pre-eclampsia and eclampsia. Semin Perinatol 33(3):130\u2013137","journal-title":"Semin Perinatol"},{"issue":"4","key":"2810_CR30","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/JIM.0000000000000189","volume":"63","author":"F Aykas","year":"2015","unstructured":"Aykas F et al (2015) Persistence of cardiovascular risk factors in women with previous preeclampsia: a long-term follow-up study. J Investig Med 63(4):641\u2013645","journal-title":"J Investig Med"},{"issue":"6","key":"2810_CR31","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/0002-9378(56)90437-9","volume":"71","author":"H Acosta-Sison","year":"1956","unstructured":"Acosta-Sison H (1956) The relationship of hydatidiform mole to pre-eclampsia and eclampsia; a study of 85 cases. Am J Obstet Gynecol 71(6):1279\u20131282","journal-title":"Am J Obstet Gynecol"},{"issue":"5-6","key":"2810_CR32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1053\/plac.1999.0390","volume":"20","author":"E Jauniaux","year":"1999","unstructured":"Jauniaux E (1999) Partial moles: from postnatal to prenatal diagnosis. Placenta 20(5-6):379\u2013388","journal-title":"Placenta"},{"key":"2810_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jri.2019.07.004","volume":"134-135","author":"Staff A.C","year":"2019","unstructured":"Staff A.C (2019) The two-stage placental model of preeclampsia: an update. J Reprod Immunol 134-135:1\u201310","journal-title":"J Reprod Immunol"},{"issue":"3","key":"2810_CR34","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2217\/epi-2016-0103","volume":"9","author":"BT Mayne","year":"2017","unstructured":"Mayne BT et al (2017) Accelerated placental aging in early onset preeclampsia pregnancies identified by DNA methylation. Epigenomics 9(3):279\u2013289","journal-title":"Epigenomics"},{"issue":"9","key":"2810_CR35","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1093\/jn\/134.9.2169","volume":"134","author":"G Wu","year":"2004","unstructured":"Wu G et al (2004) Maternal nutrition and fetal development. J Nutr 134(9):2169\u20132172","journal-title":"J Nutr"},{"issue":"2","key":"2810_CR36","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ajog.2005.08.065","volume":"194","author":"LE Mignini","year":"2006","unstructured":"Mignini LE, Villar J, Khan KS (2006) Mapping the theories of preeclampsia: the need for systematic reviews of mechanisms of the disease. Am J Obstet Gynecol 194(2):317\u2013321","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2810_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1469-7580.2008.01039.x","volume":"215","author":"GS Whitley","year":"2009","unstructured":"Whitley GS, Cartwright JE (2009) Trophoblast-mediated spiral artery remodelling: a role for apoptosis. J Anat 215(1):21\u201326","journal-title":"J Anat"},{"issue":"6","key":"2810_CR38","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/cmi.2014.63","volume":"11","author":"PD Lima","year":"2014","unstructured":"Lima PD et al (2014) Leukocyte driven-decidual angiogenesis in early pregnancy. Cell Mol Immunol 11(6):522\u2013537","journal-title":"Cell Mol Immunol"},{"issue":"8","key":"2810_CR39","doi-asserted-by":"publisher","first-page":"6259","DOI":"10.1007\/s11033-020-05644-8","volume":"47","author":"EA de Souza","year":"2020","unstructured":"de Souza EA, Pisani LP (2020) The relationship among vitamin D, TLR4 pathway and preeclampsia. Mol Biol Rep 47(8):6259\u20136267","journal-title":"Mol Biol Rep"},{"issue":"9461","key":"2810_CR40","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0140-6736(05)17987-2","volume":"365","author":"B Sibai","year":"2005","unstructured":"Sibai B, Dekker G, Kupferminc M (2005) Pre-eclampsia. Lancet 365(9461):785\u2013799","journal-title":"Lancet"},{"issue":"1","key":"2810_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ecl.2005.09.003","volume":"35","author":"CG Solomon","year":"2006","unstructured":"Solomon CG, Seely EW (2006) Hypertension in pregnancy. Endocrinol Metab Clin North Am 35(1):157\u2013171","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"10297","key":"2810_CR42","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0140-6736(20)32335-7","volume":"398","author":"LC Chappell","year":"2021","unstructured":"Chappell LC et al (2021) Pre-eclampsia. Lancet 398(10297):341\u2013354","journal-title":"Lancet"},{"issue":"1","key":"2810_CR43","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ajog.2005.07.049","volume":"195","author":"RB Ness","year":"2006","unstructured":"Ness RB, Sibai BM (2006) Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 195(1):40\u201349","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2810_CR44","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3892\/etm.2015.2280","volume":"9","author":"D Kappou","year":"2015","unstructured":"Kappou D et al (2015) Role of the angiopoietin\/Tie system in pregnancy (Review). Exp Ther Med 9(4):1091\u20131096","journal-title":"Exp Ther Med"},{"issue":"10183","key":"2810_CR45","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/S0140-6736(18)33212-4","volume":"393","author":"KE Duhig","year":"2019","unstructured":"Duhig KE et al (2019) Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial. Lancet 393(10183):1807\u20131818","journal-title":"Lancet"},{"issue":"1","key":"2810_CR46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/jcla.21819","volume":"30","author":"G Rath","year":"2016","unstructured":"Rath G et al (2016) HIF-1 Alpha and placental growth factor in pregnancies complicated with preeclampsia: a qualitative and quantitative analysis. J Clin Lab Anal 30(1):75\u201383","journal-title":"J Clin Lab Anal"},{"issue":"5","key":"2810_CR47","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1172\/JCI17189","volume":"111","author":"SE Maynard","year":"2003","unstructured":"Maynard SE et al (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111(5):649\u2013658","journal-title":"J Clin Invest"},{"issue":"6","key":"2810_CR48","doi-asserted-by":"publisher","first-page":"782 e1","DOI":"10.1016\/j.ajog.2016.07.056","volume":"215","author":"AM Holme","year":"2016","unstructured":"Holme AM et al (2016) In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies. Am J Obstet Gynecol 215(6):782 e1\u2013782 e9","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"2810_CR49","doi-asserted-by":"publisher","first-page":"5402","DOI":"10.3390\/ijms22105402","volume":"22","author":"N Gebara","year":"2021","unstructured":"Gebara N et al (2021) Angiogenic properties of placenta-derived extracellular vesicles in normal pregnancy and in preeclampsia. Int J Mol Sci 22(10):5402","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2810_CR50","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1055\/s-2007-1016254","volume":"16","author":"ST Davidge","year":"1998","unstructured":"Davidge ST (1998) Oxidative stress and altered endothelial cell function in preeclampsia. Semin Reprod Endocrinol 16(1):65\u201373","journal-title":"Semin Reprod Endocrinol"},{"issue":"5","key":"2810_CR51","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/0002-9378(89)90665-0","volume":"161","author":"JM Roberts","year":"1989","unstructured":"Roberts JM et al (1989) Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161(5):1200\u20131204","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2810_CR52","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1046\/j.1471-0528.2003.02030.x","volume":"110","author":"L Bowyer","year":"2003","unstructured":"Bowyer L, Brown MA, Jones M (2003) Forearm blood flow in pre-eclampsia. BJOG 110(4):383\u2013391","journal-title":"BJOG"},{"issue":"4","key":"2810_CR53","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/01.hjh.0000217859.27864.19","volume":"24","author":"KH Lampinen","year":"2006","unstructured":"Lampinen KH et al (2006) Impaired vascular dilatation in women with a history of pre-eclampsia. J Hypertens 24(4):751\u2013756","journal-title":"J Hypertens"},{"issue":"9368","key":"2810_CR54","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/S0140-6736(03)13177-7","volume":"361","author":"MD Savvidou","year":"2003","unstructured":"Savvidou MD et al (2003) Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 361(9368):1511\u20131517","journal-title":"Lancet"},{"issue":"12","key":"2810_CR55","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1001\/jama.285.12.1607","volume":"285","author":"JC Chambers","year":"2001","unstructured":"Chambers JC et al (2001) Association of maternal endothelial dysfunction with preeclampsia. JAMA 285(12):1607\u20131612","journal-title":"JAMA"},{"issue":"2 Pt 1","key":"2810_CR56","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1161\/01.HYP.30.2.247","volume":"30","author":"AP Cockell","year":"1997","unstructured":"Cockell AP, Poston L (1997) Flow-mediated vasodilatation is enhanced in normal pregnancy but reduced in preeclampsia. Hypertension 30(2 Pt 1):247\u2013251","journal-title":"Hypertension"},{"issue":"1","key":"2810_CR57","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/S0002-9378(00)41620-0","volume":"183","author":"KR Kublickiene","year":"2000","unstructured":"Kublickiene KR et al (2000) Preeclampsia: evidence for impaired shear stress-mediated nitric oxide release in uterine circulation. Am J Obstet Gynecol 183(1):160\u2013166","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2810_CR58","first-page":"941","volume":"84","author":"L Deng","year":"1994","unstructured":"Deng L et al (1994) Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia. Obstet Gynecol 84(6):941\u2013945","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2810_CR59","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0020-7292(96)02755-5","volume":"55","author":"M Shaarawy","year":"1996","unstructured":"Shaarawy M, Didy HE (1996) Thrombomodulin, plasminogen activator inhibitor type 1 (PAI-1) and fibronectin as biomarkers of endothelial damage in preeclampsia and eclampsia. Int J Gynaecol Obstet 55(2):135\u2013139","journal-title":"Int J Gynaecol Obstet"},{"key":"2810_CR60","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1471-2172-11-59","volume":"11","author":"A Szarka","year":"2010","unstructured":"Szarka A et al (2010) Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol 11:59","journal-title":"BMC Immunol"},{"issue":"3","key":"2810_CR61","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/cvr\/cvq346","volume":"89","author":"T Cindrova-Davies","year":"2011","unstructured":"Cindrova-Davies T et al (2011) Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling. Cardiovasc Res 89(3):671\u2013679","journal-title":"Cardiovasc Res"},{"issue":"1","key":"2810_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0002-9378(74)90170-7","volume":"120","author":"NF Gant","year":"1974","unstructured":"Gant NF et al (1974) A clinical test useful for predicting the development of acute hypertension in pregnancy. Am J Obstet Gynecol 120(1):1\u20137","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2810_CR63","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/jhh.2011.29","volume":"26","author":"PK Aggarwal","year":"2012","unstructured":"Aggarwal PK et al (2012) The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia. J Hum Hypertens 26(4):236\u2013241","journal-title":"J Hum Hypertens"},{"issue":"6 Pt 1","key":"2810_CR64","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/0002-9378(91)90017-L","volume":"165","author":"YP Wang","year":"1991","unstructured":"Wang YP et al (1991) The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood. Am J Obstet Gynecol 165(6 Pt 1):1695\u20131700","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2810_CR65","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/0002-9378(93)90389-Z","volume":"168","author":"AL McCarthy","year":"1993","unstructured":"McCarthy AL et al (1993) Abnormal endothelial cell function of resistance arteries from women with preeclampsia. Am J Obstet Gynecol 168(4):1323\u20131330","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2810_CR66","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000074824","volume":"56","author":"A Var","year":"2003","unstructured":"Var A et al (2003) Endothelial dysfunction in preeclampsia. Increased homocysteine and decreased nitric oxide levels. Gynecol Obstet Invest 56(4):221\u2013224","journal-title":"Gynecol Obstet Invest"},{"issue":"6","key":"2810_CR67","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1016\/S0002-9378(96)70123-0","volume":"175","author":"GA Knock","year":"1996","unstructured":"Knock GA, Poston L (1996) Bradykinin-mediated relaxation of isolated maternal resistance arteries in normal pregnancy and preeclampsia. Am J Obstet Gynecol 175(6):1668\u20131674","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2810_CR68","doi-asserted-by":"publisher","first-page":"R510","DOI":"10.1152\/ajpregu.00458.2007","volume":"294","author":"L Luksha","year":"2008","unstructured":"Luksha L et al (2008) Endothelium-derived hyperpolarizing factor in preeclampsia: heterogeneous contribution, mechanisms, and morphological prerequisites. Am J Physiol Regul Integr Comp Physiol 294(2):R510\u2013R519","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"2","key":"2810_CR69","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1172\/JCI557","volume":"101","author":"IF Pascoal","year":"1998","unstructured":"Pascoal IF et al (1998) Preeclampsia selectively impairs endothelium-dependent relaxation and leads to oscillatory activity in small omental arteries. J Clin Invest 101(2):464\u2013470","journal-title":"J Clin Invest"},{"issue":"2","key":"2810_CR70","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.preghy.2011.11.005","volume":"2","author":"JJ Reho","year":"2012","unstructured":"Reho JJ et al (2012) Increased myogenic reactivity of uterine arteries from pregnant rats with reduced uterine perfusion pressure. Pregnancy Hypertens 2(2):106\u2013114","journal-title":"Pregnancy Hypertens"},{"issue":"3","key":"2810_CR71","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/jwh.2015.5414","volume":"25","author":"D Enkhmaa","year":"2016","unstructured":"Enkhmaa D et al (2016) Preeclampsia and vascular function: a window to future cardiovascular disease risk. J Womens Health (Larchmt) 25(3):284\u2013291","journal-title":"J Womens Health (Larchmt)"},{"issue":"24","key":"2810_CR72","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1161\/CIRCULATIONAHA.109.853127","volume":"123","author":"CE Powe","year":"2011","unstructured":"Powe CE, Levine RJ, Karumanchi SA (2011) Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 123(24):2856\u20132869","journal-title":"Circulation"},{"issue":"8","key":"2810_CR73","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1042\/CS20190266","volume":"134","author":"AC Kelly","year":"2020","unstructured":"Kelly AC, Powell TL, Jansson T (2020) Placental function in maternal obesity. Clin Sci (Lond) 134(8):961\u2013984","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"2810_CR74","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1017\/S0029665122001914","volume":"81","author":"I Inzani","year":"2022","unstructured":"Inzani I, Ozanne SE (2022) Programming by maternal obesity: a pathway to poor cardiometabolic health in the offspring. Proc Nutr Soc 81(3):227\u2013242","journal-title":"Proc Nutr Soc"},{"issue":"1","key":"2810_CR75","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1471-0528.2000.tb11586.x","volume":"107","author":"R Hayman","year":"2000","unstructured":"Hayman R et al (2000) Plasma from women with pre-eclampsia induces an in vitro alteration in the endothelium-dependent behaviour of myometrial resistance arteries. BJOG 107(1):108\u2013115","journal-title":"BJOG"},{"issue":"2","key":"2810_CR76","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1161\/01.HYP.0000153461.58298.a4","volume":"45","author":"J Myers","year":"2005","unstructured":"Myers J et al (2005) In preeclampsia, the circulating factors capable of altering in vitro endothelial function precede clinical disease. Hypertension 45(2):258\u2013263","journal-title":"Hypertension"},{"issue":"11","key":"2810_CR77","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/ncpneph0623","volume":"3","author":"VD Garovic","year":"2007","unstructured":"Garovic VD, Hayman SR (2007) Hypertension in pregnancy: an emerging risk factor for cardiovascular disease. Nat Clin Pract Nephrol 3(11):613\u2013622","journal-title":"Nat Clin Pract Nephrol"},{"issue":"4","key":"2810_CR78","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.preghy.2012.02.002","volume":"2","author":"N Lazzarin","year":"2012","unstructured":"Lazzarin N et al (2012) Hypertension in pregnancy and endothelial activation: an emerging risk factor for cardiovascular disease. Pregnancy Hypertens 2(4):393\u2013397","journal-title":"Pregnancy Hypertens"},{"issue":"1","key":"2810_CR79","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejogrb.2010.11.017","volume":"155","author":"N Vedmedovska","year":"2011","unstructured":"Vedmedovska N et al (2011) Placental pathology in fetal growth restriction. Eur J Obstet Gynecol Reprod Biol 155(1):36\u201340","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"2810_CR80","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.placenta.2014.03.021","volume":"35","author":"S Triunfo","year":"2014","unstructured":"Triunfo S et al (2014) Angiogenic factors at diagnosis of late-onset small-for-gestational age and histological placental underperfusion. Placenta 35(6):398\u2013403","journal-title":"Placenta"},{"issue":"2","key":"2810_CR81","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/ncpneph0035","volume":"1","author":"M Noris","year":"2005","unstructured":"Noris M, Perico N, Remuzzi G (2005) Mechanisms of disease: pre-eclampsia. Nat Clin Pract Nephrol 1(2):98\u2013114","journal-title":"Nat Clin Pract Nephrol"},{"issue":"2","key":"2810_CR82","doi-asserted-by":"publisher","first-page":"283 e1","DOI":"10.1016\/j.ajog.2015.08.050","volume":"214","author":"R Sukenik-Halevy","year":"2016","unstructured":"Sukenik-Halevy R et al (2016) Telomere homeostasis in trophoblasts and in cord blood cells from pregnancies complicated with preeclampsia. Am J Obstet Gynecol 214(2):283 e1\u2013283 e7","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2810_CR83","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00418-016-1435-6","volume":"146","author":"AP Londero","year":"2016","unstructured":"Londero AP et al (2016) Placental aging and oxidation damage in a tissue micro-array model: an immunohistochemistry study. Histochem Cell Biol 146(2):191\u2013204","journal-title":"Histochem Cell Biol"},{"issue":"6","key":"2810_CR84","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3346\/jkms.2015.30.6.770","volume":"30","author":"JI Yang","year":"2015","unstructured":"Yang JI et al (2015) The proteomic analysis of human placenta with pre-eclampsia and normal pregnancy. J Korean Med Sci 30(6):770\u2013778","journal-title":"J Korean Med Sci"},{"issue":"1 Pt 1","key":"2810_CR85","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/0002-9378(95)90113-2","volume":"172","author":"SA Friedman","year":"1995","unstructured":"Friedman SA et al (1995) Biochemical corroboration of endothelial involvement in severe preeclampsia. Am J Obstet Gynecol 172(1 Pt 1):202\u2013203","journal-title":"Am J Obstet Gynecol"},{"key":"2810_CR86","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jri.2017.10.048","volume":"125","author":"MD Salazar Garcia","year":"2018","unstructured":"Salazar Garcia MD et al (2018) Early pregnancy immune biomarkers in peripheral blood may predict preeclampsia. J Reprod Immunol 125:25\u201331","journal-title":"J Reprod Immunol"},{"issue":"1","key":"2810_CR87","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13293-019-0263-5","volume":"10","author":"S Suvakov","year":"2019","unstructured":"Suvakov S et al (2019) Targeting senescence improves angiogenic potential of adipose-derived mesenchymal stem cells in patients with preeclampsia. Biol Sex Differ 10(1):49","journal-title":"Biol Sex Differ"},{"key":"2810_CR88","doi-asserted-by":"publisher","first-page":"103536","DOI":"10.1016\/j.ebiom.2021.103536","volume":"70","author":"S Suvakov","year":"2021","unstructured":"Suvakov S et al (2021) Epigenetic and senescence markers indicate an accelerated ageing-like state in women with preeclamptic pregnancies. EBioMedicine 70:103536","journal-title":"EBioMedicine"},{"key":"2810_CR89","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/j.placenta.2008.11.021","volume":"30","author":"CW Redman","year":"2009","unstructured":"Redman CW, Sargent IL (2009) Placental stress and pre-eclampsia: a revised view. Placenta 30:S38\u2013S42","journal-title":"Placenta"},{"issue":"7","key":"2810_CR90","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrendo.2009.102","volume":"5","author":"PD Gluckman","year":"2009","unstructured":"Gluckman PD et al (2009) Epigenetic mechanisms that underpin metabolic and cardiovascular diseases. Nat Rev Endocrinol 5(7):401","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"2810_CR91","doi-asserted-by":"publisher","first-page":"404 e1","DOI":"10.1016\/j.ajog.2017.03.029","volume":"217","author":"HT Wolf","year":"2017","unstructured":"Wolf HT et al (2017) Multivitamin use and adverse birth outcomes in high-income countries: a systematic review and meta-analysis. Am J Obstet Gynecol 217(4):404 e1\u2013404 e30","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2810_CR92","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1365-2796.2007.01809.x","volume":"261","author":"DJ Barker","year":"2007","unstructured":"Barker DJ (2007) The origins of the developmental origins theory. J Intern Med 261(5):412\u2013417","journal-title":"J Intern Med"},{"issue":"12","key":"2810_CR93","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1056\/NEJM200103223441201","volume":"344","author":"MS Esplin","year":"2001","unstructured":"Esplin MS et al (2001) Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med 344(12):867\u2013872","journal-title":"N Engl J Med"},{"issue":"6998","key":"2810_CR94","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nature02725","volume":"430","author":"P Bateson","year":"2004","unstructured":"Bateson P et al (2004) Developmental plasticity and human health. Nature 430(6998):419\u2013421","journal-title":"Nature"},{"issue":"1","key":"2810_CR95","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1056\/NEJMra0708473","volume":"359","author":"PD Gluckman","year":"2008","unstructured":"Gluckman PD et al (2008) Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 359(1):61\u201373","journal-title":"N Engl J Med"},{"issue":"5 Suppl","key":"2810_CR96","doi-asserted-by":"publisher","first-page":"1344S","DOI":"10.1093\/ajcn\/71.5.1344s","volume":"71","author":"KM Godfrey","year":"2000","unstructured":"Godfrey KM, Barker DJ (2000) Fetal nutrition and adult disease. Am J Clin Nutr 71(5 Suppl):1344S\u20131352S","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"2810_CR97","doi-asserted-by":"publisher","first-page":"506","DOI":"10.5468\/ogs.2017.60.6.506","volume":"60","author":"EJ Kwon","year":"2017","unstructured":"Kwon EJ, Kim YJ (2017) What is fetal programming?: a lifetime health is under the control of in utero health. Obstet Gynecol Sci 60(6):506\u2013519","journal-title":"Obstet Gynecol Sci"},{"issue":"10","key":"2810_CR98","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.3390\/nu12103054","volume":"12","author":"AWC Man","year":"2020","unstructured":"Man AWC et al (2020) Involvement of gut microbiota, microbial metabolites and interaction with polyphenol in host immunometabolism. Nutrients 12(10):3054","journal-title":"Nutrients"},{"issue":"9","key":"2810_CR99","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00109-020-01949-0","volume":"98","author":"AWC Man","year":"2020","unstructured":"Man AWC et al (2020) Fetal programming effects of pentaerythritol tetranitrate in a rat model of superimposed preeclampsia. J Mol Med (Berl) 98(9):1287\u20131299","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"2810_CR100","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1161\/HYPERTENSIONAHA.111.187559","volume":"60","author":"S Kulandavelu","year":"2012","unstructured":"Kulandavelu S et al (2012) Endothelial nitric oxide synthase deficiency reduces uterine blood flow, spiral artery elongation, and placental oxygenation in pregnant mice. Hypertension 60(1):231\u2013238","journal-title":"Hypertension"},{"issue":"3","key":"2810_CR101","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1530\/JOE-11-0053","volume":"210","author":"DS Boeldt","year":"2011","unstructured":"Boeldt DS, Yi FX, Bird IM (2011) eNOS activation and NO function: pregnancy adaptive programming of capacitative entry responses alters nitric oxide (NO) output in vascular endothelium-new insights into eNOS regulation through adaptive cell signaling. J Endocrinol 210(3):243\u2013258","journal-title":"J Endocrinol"},{"issue":"4","key":"2810_CR102","first-page":"180","volume":"16","author":"A Devendran","year":"2015","unstructured":"Devendran A et al (2015) Allele, genotype and haplotype structures of functional polymorphic variants in endothelial nitric oxide synthase (eNOS), angiotensinogen (ACE) and aldosterone synthase (CYP11B2) genes in healthy pregnant women of Indian ethnicity. J Reprod Infertil 16(4):180\u2013192","journal-title":"J Reprod Infertil"},{"issue":"4","key":"2810_CR103","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1292\/jvms.71.495","volume":"71","author":"T Suzuki","year":"2009","unstructured":"Suzuki T et al (2009) Gestational changes in production of NO and expression of NOS mRNA isoforms in the rat placenta. J Vet Med Sci 71(4):495\u2013498","journal-title":"J Vet Med Sci"},{"issue":"1","key":"2810_CR104","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12978-021-01213-9","volume":"18","author":"G Shaheen","year":"2021","unstructured":"Shaheen G et al (2021) Association of endothelial nitric oxide synthase gene variants with preeclampsia. Reprod Health 18(1):163","journal-title":"Reprod Health"},{"issue":"5","key":"2810_CR105","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/hr.2010.23","volume":"33","author":"PK Aggarwal","year":"2010","unstructured":"Aggarwal PK, Jain V, Jha V (2010) Endothelial nitric oxide synthase, angiotensin-converting enzyme and angiotensinogen gene polymorphisms in hypertensive disorders of pregnancy. Hypertens Res 33(5):473\u2013477","journal-title":"Hypertens Res"},{"issue":"4","key":"2810_CR106","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1681\/ASN.2011040369","volume":"23","author":"F Li","year":"2012","unstructured":"Li F et al (2012) eNOS deficiency acts through endothelin to aggravate sFlt-1-induced pre-eclampsia-like phenotype. J Am Soc Nephrol 23(4):652\u2013660","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2810_CR107","doi-asserted-by":"publisher","first-page":"R499","DOI":"10.1152\/ajpregu.00355.2017","volume":"314","author":"SA Marshall","year":"2018","unstructured":"Marshall SA et al (2018) Animal models of preeclampsia: translational failings and why. Am J Physiol Regul Integr Comp Physiol 314(4):R499\u2013R508","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"6","key":"2810_CR108","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1600-0897.2010.00929.x","volume":"65","author":"N Sunderland","year":"2011","unstructured":"Sunderland N, Hennessy A, Makris A (2011) Animal models of pre-eclampsia. Am J Reprod Immunol 65(6):533\u2013541","journal-title":"Am J Reprod Immunol"},{"issue":"2S","key":"2810_CR109","doi-asserted-by":"publisher","first-page":"S973","DOI":"10.1016\/j.ajog.2020.10.025","volume":"226","author":"BA Bakrania","year":"2022","unstructured":"Bakrania BA, George EM, Granger JP (2022) Animal models of preeclampsia: investigating pathophysiology and therapeutic targets. Am J Obstet Gynecol 226(2S):S973\u2013S987","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2810_CR110","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1159\/000484314","volume":"44","author":"M Lemery Magnin","year":"2018","unstructured":"Lemery Magnin M et al (2018) Assessment of placental perfusion in the preeclampsia L-NAME rat model with high-field dynamic contrast-enhanced MRI. Fetal Diagn Ther 44(4):277\u2013284","journal-title":"Fetal Diagn Ther"},{"key":"2810_CR111","doi-asserted-by":"crossref","unstructured":"de Alwis N et al (2022) The L-NAME mouse model of preeclampsia and impact to long-term maternal cardiovascular health. Life Science Alliance 5(12)","DOI":"10.26508\/lsa.202201517"},{"issue":"5","key":"2810_CR112","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/0002-9378(94)90141-4","volume":"171","author":"AL Diket","year":"1994","unstructured":"Diket AL et al (1994) Nitric oxide inhibition causes intrauterine growth retardation and hind-limb disruptions in rats. Am J Obstet Gynecol 171(5):1243\u20131250","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2810_CR113","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1172\/JCI17423","volume":"111","author":"V Eremina","year":"2003","unstructured":"Eremina V et al (2003) Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 111(5):707\u2013716","journal-title":"J Clin Invest"},{"issue":"1","key":"2810_CR114","doi-asserted-by":"publisher","first-page":"R62","DOI":"10.1152\/ajpregu.00377.2014","volume":"309","author":"EE Gillis","year":"2015","unstructured":"Gillis EE et al (2015) The Dahl salt-sensitive rat is a spontaneous model of superimposed preeclampsia. Am J Physiol Regul Integr Comp Physiol 309(1):R62\u2013R70","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"5","key":"2810_CR115","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1161\/HYPERTENSIONAHA.118.12454","volume":"73","author":"F Terstappen","year":"2019","unstructured":"Terstappen F et al (2019) Prenatal Sildenafil therapy improves cardiovascular function in fetal growth restricted offspring of Dahl salt-sensitive rats. Hypertension 73(5):1120\u20131127","journal-title":"Hypertension"},{"issue":"S1","key":"2810_CR116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fasebj.2020.34.s1.03903","volume":"34","author":"JH Dasinger","year":"2020","unstructured":"Dasinger JH et al (2020) Development of maternal syndrome in the Dahl salt-sensitive rats is dependent on T cells. Faseb J 34(S1):1\u20131","journal-title":"Faseb J"},{"issue":"2","key":"2810_CR117","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3390\/biom10020302","volume":"10","author":"F Terstappen","year":"2020","unstructured":"Terstappen F et al (2020) Sodium thiosulfate in the pregnant Dahl salt-sensitive rat, a model of preeclampsia. Biomolecules 10(2):302","journal-title":"Biomolecules"},{"issue":"3","key":"2810_CR118","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.118.12097","volume":"73","author":"HR Turbeville","year":"2019","unstructured":"Turbeville HR et al (2019) Superimposed preeclampsia exacerbates postpartum renal injury despite lack of long-term blood pressure difference in the Dahl salt-sensitive rat. Hypertension 73(3):650\u2013658","journal-title":"Hypertension"},{"issue":"6","key":"2810_CR119","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.semnephrol.2004.07.011","volume":"24","author":"E Podjarny","year":"2004","unstructured":"Podjarny E, Losonczy G, Baylis C (2004) Animal models of preeclampsia. Semin Nephrol 24(6):596\u2013606","journal-title":"Semin Nephrol"},{"issue":"9181","key":"2810_CR120","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S0140-6736(99)80002-6","volume":"354","author":"JM Roberts","year":"1999","unstructured":"Roberts JM, Hubel CA (1999) Is oxidative stress the link in the two-stage model of pre-eclampsia? Lancet 354(9181):788\u2013789","journal-title":"Lancet"},{"issue":"4","key":"2810_CR121","doi-asserted-by":"publisher","first-page":"E404","DOI":"10.1152\/ajpendo.00426.2013","volume":"306","author":"C Mando","year":"2014","unstructured":"Mando C et al (2014) Placental mitochondrial content and function in intrauterine growth restriction and preeclampsia. Am J Physiol Endocrinol Metab 306(4):E404\u2013E413","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"22","key":"2810_CR122","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.2174\/13816128113196660746","volume":"20","author":"S Luo","year":"2014","unstructured":"Luo S et al (2014) Molecular mechanisms of endothelial NO synthase uncoupling. Curr Pharm Des 20(22):3548\u20133553","journal-title":"Curr Pharm Des"},{"key":"2810_CR123","doi-asserted-by":"publisher","first-page":"101861","DOI":"10.1016\/j.redox.2021.101861","volume":"40","author":"P Guerby","year":"2021","unstructured":"Guerby P et al (2021) Role of oxidative stress in the dysfunction of the placental endothelial nitric oxide synthase in preeclampsia. Redox Biol 40:101861","journal-title":"Redox Biol"},{"issue":"6","key":"2810_CR124","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nm1429","volume":"12","author":"S Venkatesha","year":"2006","unstructured":"Venkatesha S et al (2006) Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12(6):642\u2013649","journal-title":"Nat Med"},{"issue":"3","key":"2810_CR125","first-page":"1731","volume":"41","author":"L Shen","year":"2018","unstructured":"Shen L et al (2018) Placenta-associated serum exosomal miR-155 derived from patients with preeclampsia inhibits eNOS expression in human umbilical vein endothelial cells. Int J Mol Med 41(3):1731\u20131739","journal-title":"Int J Mol Med"},{"issue":"12","key":"2810_CR126","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.11124\/JBISRIR-D-19-00290","volume":"18","author":"DA Nnate","year":"2020","unstructured":"Nnate DA, Mabhala M, Massey A (2020) Effectiveness of nitric oxide agents in preventing the early onset of pre-eclampsia and possible modification of metabolic factors in high-risk pregnancies: a systematic review protocol. JBI Evid Synth 18(12):2658\u20132665","journal-title":"JBI Evid Synth"},{"issue":"24","key":"2810_CR127","doi-asserted-by":"publisher","first-page":"9265","DOI":"10.1073\/pnas.84.24.9265","volume":"84","author":"LJ Ignarro","year":"1987","unstructured":"Ignarro LJ et al (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 84(24):9265\u20139269","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"2810_CR128","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.placenta.2011.06.025","volume":"32","author":"BJ Krause","year":"2011","unstructured":"Krause BJ, Hanson MA, Casanello P (2011) Role of nitric oxide in placental vascular development and function. Placenta 32(11):797\u2013805","journal-title":"Placenta"},{"issue":"9","key":"2810_CR129","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1161\/01.ATV.0000232542.42968.e3","volume":"26","author":"A Hamik","year":"2006","unstructured":"Hamik A, Wang B, Jain MK (2006) Transcriptional regulators of angiogenesis. Arterioscler Thromb Vasc Biol 26(9):1936\u20131947","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2810_CR130","doi-asserted-by":"crossref","unstructured":"McDonald CR et al (2018) Malaria in pregnancy alters l-arginine bioavailability and placental vascular development. Sci Transl Med 10(431):eaan6007","DOI":"10.1126\/scitranslmed.aan6007"},{"key":"2810_CR131","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.phrs.2017.04.011","volume":"121","author":"S Socco","year":"2017","unstructured":"Socco S et al (2017) Epigenetics: the third pillar of nitric oxide signaling. Pharmacol Res 121:52\u201358","journal-title":"Pharmacol Res"},{"issue":"24","key":"2810_CR132","doi-asserted-by":"publisher","first-page":"5299","DOI":"10.1158\/0008-5472.CAN-15-1582","volume":"75","author":"D Vasudevan","year":"2015","unstructured":"Vasudevan D et al (2015) Nitric oxide regulates gene expression in cancers by controlling histone posttranslational modifications. Cancer Res 75(24):5299\u20135308","journal-title":"Cancer Res"},{"issue":"4","key":"2810_CR133","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/S1471-4914(03)00028-5","volume":"9","author":"MW Foster","year":"2003","unstructured":"Foster MW, McMahon TJ, Stamler JS (2003) S-nitrosylation in health and disease. Trends Mol Med 9(4):160\u2013168","journal-title":"Trends Mol Med"},{"key":"2810_CR134","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.niox.2014.07.002","volume":"42","author":"AK Iyer","year":"2014","unstructured":"Iyer AK, Rojanasakul Y, Azad N (2014) Nitrosothiol signaling and protein nitrosation in cell death. Nitric Oxide 42:9\u201318","journal-title":"Nitric Oxide"},{"issue":"5","key":"2810_CR135","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1095\/biolreprod.110.090688","volume":"84","author":"HH Zhang","year":"2011","unstructured":"Zhang HH, Wang YP, Chen DB (2011) Analysis of nitroso-proteomes in normotensive and severe preeclamptic human placentas. Biol Reprod 84(5):966\u2013975","journal-title":"Biol Reprod"},{"key":"2810_CR136","first-page":"183012","volume":"1","author":"S Kulandavelu","year":"2021","unstructured":"Kulandavelu S et al (2021) S-nitrosoglutathione reductase deficiency causes aberrant placental S-nitrosylation and preeclampsia. bioRxiv 1:183012","journal-title":"bioRxiv"},{"issue":"10","key":"2810_CR137","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1515\/hsz-2016-0166","volume":"397","author":"W Liu","year":"2016","unstructured":"Liu W, Hajjar KA (2016) The annexin A2 system and angiogenesis. Biol Chem 397(10):1005\u20131016","journal-title":"Biol Chem"},{"issue":"1","key":"2810_CR138","doi-asserted-by":"publisher","first-page":"R26","DOI":"10.1152\/ajpregu.00020.2020","volume":"319","author":"JH Dasinger","year":"2020","unstructured":"Dasinger JH, Abais-Battad JM, Mattson DL (2020) Influences of environmental factors during preeclampsia. Am J Physiol Regul Integr Comp Physiol 319(1):R26\u2013R32","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"5","key":"2810_CR139","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nrendo.2016.37","volume":"12","author":"AD Gernand","year":"2016","unstructured":"Gernand AD et al (2016) Micronutrient deficiencies in pregnancy worldwide: health effects and prevention. Nat Rev Endocrinol 12(5):274\u2013289","journal-title":"Nat Rev Endocrinol"},{"key":"2810_CR140","doi-asserted-by":"crossref","unstructured":"Suchdev PS, Pe\u00f1a\u2010Rosas JP, De\u2010Regil LM (2015) Multiple micronutrient powders for home (point\u2010of\u2010use) fortification of foods in pregnant women.\u00a0Cochrane Database Syst Rev\u00a0(6):CD011158","DOI":"10.1002\/14651858.CD011158.pub2"},{"issue":"8","key":"2810_CR141","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.3390\/nu12082432","volume":"12","author":"M Massari","year":"2020","unstructured":"Massari M et al (2020) Multiple micronutrients and docosahexaenoic acid supplementation during pregnancy: a randomized controlled study. Nutrients 12(8):2432","journal-title":"Nutrients"},{"issue":"9","key":"2810_CR142","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.3390\/nu13093134","volume":"13","author":"S Santander Ballestin","year":"2021","unstructured":"Santander Ballestin S et al (2021) Is supplementation with micronutrients still necessary during pregnancy? A review. Nutrients 13(9):3134","journal-title":"Nutrients"},{"issue":"1","key":"2810_CR143","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/MOL.0000000000000044","volume":"25","author":"MA Martinez-Gonzalez","year":"2014","unstructured":"Martinez-Gonzalez MA, Bes-Rastrollo M (2014) Dietary patterns, Mediterranean diet, and cardiovascular disease. Curr Opin Lipidol 25(1):20\u201326","journal-title":"Curr Opin Lipidol"},{"issue":"20","key":"2810_CR144","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.3760\/cma.j.issn.0366-6999.20141358","volume":"127","author":"H Khemayanto","year":"2014","unstructured":"Khemayanto H, Shi B (2014) Role of Mediterranean diet in prevention and management of type 2 diabetes. Chin Med J (Engl) 127(20):3651\u20133656","journal-title":"Chin Med J (Engl)"},{"issue":"11","key":"2810_CR145","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/j.1753-4887.2009.00249.x","volume":"67","author":"H Xu","year":"2009","unstructured":"Xu H et al (2009) Role of nutrition in the risk of preeclampsia. Nutr Rev 67(11):639\u2013657","journal-title":"Nutr Rev"},{"issue":"5 Suppl 2","key":"2810_CR146","doi-asserted-by":"publisher","first-page":"1684S","DOI":"10.1093\/jn\/133.5.1684S","volume":"133","author":"JM Roberts","year":"2003","unstructured":"Roberts JM et al (2003) Nutrient involvement in preeclampsia. J Nutr 133(5 Suppl 2):1684S\u20131692S","journal-title":"J Nutr"},{"issue":"17","key":"2810_CR147","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1056\/NEJMoa054186","volume":"354","author":"AR Rumbold","year":"2006","unstructured":"Rumbold AR et al (2006) Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med 354(17):1796\u20131806","journal-title":"N Engl J Med"},{"issue":"3","key":"2810_CR148","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ajog.2006.01.068","volume":"194","author":"J Villar","year":"2006","unstructured":"Villar J et al (2006) World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol 194(3):639\u2013649","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2810_CR149","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/jn\/116.1.36","volume":"116","author":"WJ Visek","year":"1986","unstructured":"Visek WJ (1986) Arginine needs, physiological state and usual diets. A reevaluation. J Nutr 116(1):36\u201346","journal-title":"A reevaluation. J Nutr"},{"key":"2810_CR150","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1146\/annurev.pharmtox.41.1.79","volume":"41","author":"RH Boger","year":"2001","unstructured":"Boger RH, Bode-Boger SM (2001) The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol 41:79\u201399","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"9","key":"2810_CR151","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jnutbio.2005.12.001","volume":"17","author":"WS Jobgen","year":"2006","unstructured":"Jobgen WS et al (2006) Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates. J Nutr Biochem 17(9):571\u2013588","journal-title":"J Nutr Biochem"},{"issue":"4","key":"2810_CR152","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1172\/JCI115987","volume":"90","author":"MA Creager","year":"1992","unstructured":"Creager MA et al (1992) L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 90(4):1248\u20131253","journal-title":"J Clin Invest"},{"issue":"2","key":"2810_CR153","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0021-9150(96)06044-3","volume":"129","author":"MR Adams","year":"1997","unstructured":"Adams MR et al (1997) Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease. Atherosclerosis 129(2):261\u2013269","journal-title":"Atherosclerosis"},{"issue":"5","key":"2810_CR154","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1046\/j.1365-2125.1998.00803.x","volume":"46","author":"SM Bode-Boger","year":"1998","unstructured":"Bode-Boger SM et al (1998) L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship. Br J Clin Pharmacol 46(5):489\u2013497","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"2810_CR155","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/jhh.2013.100","volume":"28","author":"T Dorniak-Wall","year":"2014","unstructured":"Dorniak-Wall T et al (2014) The role of L-arginine in the prevention and treatment of pre-eclampsia: a systematic review of randomised trials. J Hum Hypertens 28(4):230\u2013235","journal-title":"J Hum Hypertens"},{"issue":"2","key":"2810_CR156","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3109\/10641955.2015.1137586","volume":"35","author":"EE Camarena Pulido","year":"2016","unstructured":"Camarena Pulido EE et al (2016) Efficacy of L-arginine for preventing preeclampsia in high-risk pregnancies: a double-blind, randomized, clinical trial. Hypertens Pregnancy 35(2):217\u2013225","journal-title":"Hypertens Pregnancy"},{"issue":"4","key":"2810_CR157","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.pathophys.2018.08.001","volume":"25","author":"GO Oludare","year":"2018","unstructured":"Oludare GO, Jinadu HD, Aro OO (2018) L-arginine attenuates blood pressure and reverses the suppression of angiogenic risk factors in a rat model of preeclampsia. Pathophysiology 25(4):389\u2013395","journal-title":"Pathophysiology"},{"issue":"7","key":"2810_CR158","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.clnu.2022.05.014","volume":"41","author":"L Xu","year":"2022","unstructured":"Xu L et al (2022) l-arginine supplementation improved neonatal outcomes in pregnancies with hypertensive disorder or intrauterine growth restriction: A systematic review and meta-analysis of randomized controlled trials. Clin Nutr 41(7):1512\u20131522","journal-title":"Clin Nutr"},{"issue":"5","key":"2810_CR159","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/advances\/nmz015","volume":"10","author":"AM Weckman","year":"2019","unstructured":"Weckman AM et al (2019) Perspective: L-arginine and L-citrulline supplementation in pregnancy: a potential strategy to improve birth outcomes in low-resource settings. Adv Nutr 10(5):765\u2013777","journal-title":"Adv Nutr"},{"issue":"2","key":"2810_CR160","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.pt.2019.12.005","volume":"36","author":"M Ngai","year":"2020","unstructured":"Ngai M et al (2020) Malaria in pregnancy and adverse birth outcomes: new mechanisms and therapeutic opportunities. Trends Parasitol 36(2):127\u2013137","journal-title":"Trends Parasitol"},{"key":"2810_CR161","first-page":"2021","volume":"10","author":"IL Aye","year":"2021","unstructured":"Aye IL et al (2021) Placental polyamines regulate acetyl-coA and histone acetylation in a sex-dependent manner. bioRxiv 10:2021","journal-title":"bioRxiv"},{"issue":"43","key":"2810_CR162","doi-asserted-by":"publisher","first-page":"35825","DOI":"10.1074\/jbc.M112.381335","volume":"287","author":"G Landau","year":"2012","unstructured":"Landau G et al (2012) Expression profiling and biochemical analysis suggest stress response as a potential mechanism inhibiting proliferation of polyamine-depleted cells. J Biol Chem 287(43):35825\u201335837","journal-title":"J Biol Chem"},{"issue":"1","key":"2810_CR163","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4062\/biomolther.2012.097","volume":"21","author":"MH Park","year":"2013","unstructured":"Park MH, Igarashi K (2013) Polyamines and their metabolites as diagnostic markers of human diseases. Biomol Ther (Seoul) 21(1):1\u20139","journal-title":"Biomol Ther (Seoul)"},{"issue":"7","key":"2810_CR164","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1071\/RD18235","volume":"31","author":"JC Fenelon","year":"2019","unstructured":"Fenelon JC, Murphy BD (2019) New functions for old factors: the role of polyamines during the establishment of pregnancy. Reprod Fertil Dev 31(7):1228\u20131239","journal-title":"Reprod Fertil Dev"},{"issue":"1","key":"2810_CR165","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/biolre\/ioy047","volume":"99","author":"FW Bazer","year":"2018","unstructured":"Bazer FW et al (2018) Mechanisms for the establishment and maintenance of pregnancy: synergies from scientific collaborations. Biol Reprod 99(1):225\u2013241","journal-title":"Biol Reprod"},{"issue":"7","key":"2810_CR166","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3390\/nu11071452","volume":"11","author":"CN Hsu","year":"2019","unstructured":"Hsu CN, Tain YL (2019) Impact of arginine nutrition and metabolism during pregnancy on offspring outcomes. Nutrients 11(7):1452","journal-title":"Nutrients"},{"key":"2810_CR167","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.foodchem.2014.03.102","volume":"161","author":"P Kalac","year":"2014","unstructured":"Kalac P (2014) Health effects and occurrence of dietary polyamines: a review for the period 2005-mid 2013. Food Chem 161:27\u201339","journal-title":"Food Chem"},{"key":"2810_CR168","doi-asserted-by":"crossref","unstructured":"Puleston DJ et al (2014) Autophagy is a critical regulator of memory CD8+ T cell formation. Elife 3:e03706","DOI":"10.7554\/eLife.03706"},{"issue":"2","key":"2810_CR169","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1476-5381.1994.tb13078.x","volume":"112","author":"C Szabo","year":"1994","unstructured":"Szabo C et al (1994) Inhibition by spermine of the induction of nitric oxide synthase in J774.2 macrophages: requirement of a serum factor. Br J Pharmacol 112(2):355\u2013356","journal-title":"Br J Pharmacol"},{"issue":"5","key":"2810_CR170","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/cbf.1766","volume":"29","author":"AA El-Kirsh","year":"2011","unstructured":"El-Kirsh AA, Abd El-Wahab HM, Abd-Ellah Sayed HF (2011) The effect of L-arginine or L-citrulline supplementation on biochemical parameters and the vascular aortic wall in high-fat and high-cholesterol-fed rats. Cell Biochem Funct 29(5):414\u2013428","journal-title":"Cell Biochem Funct"},{"issue":"30","key":"2810_CR171","doi-asserted-by":"publisher","first-page":"20022","DOI":"10.1074\/jbc.M109.021089","volume":"284","author":"JR Guerreiro","year":"2009","unstructured":"Guerreiro JR et al (2009) Argininosuccinate synthetase is a functional target for a snake venom anti-hypertensive peptide: role in arginine and nitric oxide production. J Biol Chem 284(30):20022\u201320033","journal-title":"J Biol Chem"},{"issue":"10","key":"2810_CR172","doi-asserted-by":"publisher","first-page":"e0141572","DOI":"10.1371\/journal.pone.0141572","volume":"10","author":"DJ Ham","year":"2015","unstructured":"Ham DJ et al (2015) L-Citrulline protects skeletal muscle cells from cachectic stimuli through an iNOS-dependent mechanism. PLoS One 10(10):e0141572","journal-title":"PLoS One"},{"key":"2810_CR173","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.3389\/fimmu.2018.02911","volume":"9","author":"YC Lee","year":"2018","unstructured":"Lee YC et al (2018) L-Arginine and L-Citrulline supplementation have different programming effect on regulatory T-cells function of infantile rats. Front Immunol 9:2911","journal-title":"Front Immunol"},{"issue":"3","key":"2810_CR174","doi-asserted-by":"publisher","first-page":"E582","DOI":"10.1152\/ajpendo.00398.2005","volume":"291","author":"S Osowska","year":"2006","unstructured":"Osowska S et al (2006) Citrulline modulates muscle protein metabolism in old malnourished rats. Am J Physiol Endocrinol Metab 291(3):E582\u2013E586","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"2810_CR175","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.clnu.2014.04.019","volume":"34","author":"M Jourdan","year":"2015","unstructured":"Jourdan M et al (2015) Citrulline stimulates muscle protein synthesis in the post-absorptive state in healthy people fed a low-protein diet - a pilot study. Clin Nutr 34(3):449\u2013456","journal-title":"Clin Nutr"},{"key":"2810_CR176","doi-asserted-by":"crossref","unstructured":"Khalaf D et al (2019) The effects of oral l-Arginine and l-Citrulline supplementation on blood pressure. Nutrients 11(7)","DOI":"10.3390\/nu11071679"},{"key":"2810_CR177","doi-asserted-by":"crossref","unstructured":"Man AW et al (2022) L-citrulline ameliorates pathophysiology in a rat model of superimposed preeclampsia. Br J Pharmacol:1\u201317","DOI":"10.1101\/2021.08.24.457514"},{"issue":"3","key":"2810_CR178","doi-asserted-by":"publisher","first-page":"R364","DOI":"10.1152\/ajpregu.00115.2020","volume":"321","author":"M Gemmel","year":"2021","unstructured":"Gemmel M et al (2021) l-Citrulline supplementation during pregnancy improves perinatal and postpartum maternal vascular function in a mouse model of preeclampsia. Am J Physiol Regul Integr Comp Physiol 321(3):R364\u2013R376","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"3","key":"2810_CR179","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3945\/jn.115.221267","volume":"146","author":"A Bourdon","year":"2016","unstructured":"Bourdon A et al (2016) L-Citrulline supplementation enhances fetal growth and protein synthesis in rats with intrauterine growth restriction. J Nutr 146(3):532\u2013541","journal-title":"J Nutr"},{"issue":"1","key":"2810_CR180","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.niox.2010.03.005","volume":"23","author":"YL Tain","year":"2010","unstructured":"Tain YL et al (2010) Effects of maternal L-citrulline supplementation on renal function and blood pressure in offspring exposed to maternal caloric restriction: the impact of nitric oxide pathway. Nitric Oxide 23(1):34\u201341","journal-title":"Nitric Oxide"},{"issue":"6","key":"2810_CR181","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1161\/HYPERTENSIONAHA.107.095794","volume":"50","author":"MP Koeners","year":"2007","unstructured":"Koeners MP et al (2007) Maternal supplementation with citrulline increases renal nitric oxide in young spontaneously hypertensive rats and has long-term antihypertensive effects. Hypertension 50(6):1077\u20131084","journal-title":"Hypertension"},{"issue":"5","key":"2810_CR182","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3109\/10715762.2014.895341","volume":"48","author":"YL Tain","year":"2014","unstructured":"Tain YL et al (2014) Maternal citrulline supplementation prevents prenatal dexamethasone-induced programmed hypertension. Free Radic Res 48(5):580\u2013586","journal-title":"Free Radic Res"},{"issue":"2","key":"2810_CR183","first-page":"95","volume":"91","author":"Y Chen","year":"2018","unstructured":"Chen Y, Michalak M, Agellon LB (2018) Importance of nutrients and nutrient metabolism on human health. Yale J Biol Med 91(2):95\u2013103","journal-title":"Yale J Biol Med"},{"issue":"8","key":"2810_CR184","doi-asserted-by":"publisher","first-page":"118","DOI":"10.4103\/0973-7847.70902","volume":"4","author":"V Lobo","year":"2010","unstructured":"Lobo V et al (2010) Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev 4(8):118\u2013126","journal-title":"Pharmacogn Rev"},{"issue":"2","key":"2810_CR185","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1067\/mob.2001.116687","volume":"185","author":"T Clausen","year":"2001","unstructured":"Clausen T et al (2001) High intake of energy, sucrose, and polyunsaturated fatty acids is associated with increased risk of preeclampsia. Am J Obstet Gynecol 185(2):451\u2013458","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2810_CR186","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/00001648-199505000-00007","volume":"6","author":"MA Williams","year":"1995","unstructured":"Williams MA et al (1995) Omega-3 fatty acids in maternal erythrocytes and risk of preeclampsia. Epidemiology 6(3):232\u2013237","journal-title":"Epidemiology"},{"issue":"2","key":"2810_CR187","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11745-999-0348-x","volume":"34","author":"SM Innis","year":"1999","unstructured":"Innis SM et al (1999) Neonatal polyunsaturated fatty acid metabolism. Lipids 34(2):139\u2013149","journal-title":"Lipids"},{"issue":"4","key":"2810_CR188","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.surneu.2005.10.023","volume":"65","author":"JC Maroon","year":"2006","unstructured":"Maroon JC, Bost JW (2006) Omega-3 fatty acids (fish oil) as an anti-inflammatory: an alternative to nonsteroidal anti-inflammatory drugs for discogenic pain. Surg Neurol 65(4):326\u2013331","journal-title":"Surg Neurol"},{"key":"2810_CR189","doi-asserted-by":"publisher","first-page":"f3706","DOI":"10.1136\/bmj.f3706","volume":"346","author":"JS Zheng","year":"2013","unstructured":"Zheng JS et al (2013) Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies. Bmj 346:f3706","journal-title":"Bmj"},{"issue":"20","key":"2810_CR190","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/j.jacc.2011.06.063","volume":"58","author":"D Mozaffarian","year":"2011","unstructured":"Mozaffarian D, Wu JH (2011) Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 58(20):2047\u20132067","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2810_CR191","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1006\/bbrc.1997.6328","volume":"232","author":"Y Okuda","year":"1997","unstructured":"Okuda Y et al (1997) Eicosapentaenoic acid enhances nitric oxide production by cultured human endothelial cells. Biochem Biophys Res Commun 232(2):487\u2013491","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2810_CR192","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0014-5793(00)02351-6","volume":"487","author":"M Omura","year":"2001","unstructured":"Omura M et al (2001) Eicosapentaenoic acid (EPA) induces Ca(2+)-independent activation and translocation of endothelial nitric oxide synthase and endothelium-dependent vasorelaxation. FEBS Lett 487(3):361\u2013366","journal-title":"FEBS Lett"},{"issue":"7","key":"2810_CR193","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/s41430-018-0290-z","volume":"73","author":"M Arvizu","year":"2019","unstructured":"Arvizu M et al (2019) Fat intake during pregnancy and risk of preeclampsia: a prospective cohort study in Denmark. Eur J Clin Nutr 73(7):1040\u20131048","journal-title":"Eur J Clin Nutr"},{"issue":"1","key":"2810_CR194","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.tjog.2019.11.002","volume":"59","author":"F Bakouei","year":"2020","unstructured":"Bakouei F et al (2020) Efficacy of n-3 fatty acids supplementation on the prevention of pregnancy induced-hypertension or preeclampsia: A systematic review and meta-analysis. Taiwan J Obstet Gynecol 59(1):8\u201315","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"5","key":"2810_CR195","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1530\/REP-13-0376","volume":"147","author":"ML Jones","year":"2014","unstructured":"Jones ML, Mark PJ, Waddell BJ (2014) Maternal dietary omega-3 fatty acids and placental function. Reproduction 147(5):R143\u2013R152","journal-title":"Reproduction"},{"key":"2810_CR196","doi-asserted-by":"publisher","first-page":"106100","DOI":"10.1016\/j.phrs.2022.106100","volume":"177","author":"FD Firouzabadi","year":"2022","unstructured":"Firouzabadi FD, Shab-Bidar S, Jayedi A (2022) The effects of omega-3 polyunsaturated fatty acids supplementation in pregnancy, lactation, and infancy: an umbrella review of meta-analyses of randomized trials. Pharmacol Res 177:106100","journal-title":"Pharmacol Res"},{"key":"2810_CR197","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3389\/fgene.2019.01050","volume":"10","author":"M Bianchi","year":"2019","unstructured":"Bianchi M et al (2019) Maternal intake of n-3 polyunsaturated fatty acids during pregnancy is associated with differential methylation profiles in cord blood white cells. Front Genet 10:1050","journal-title":"Front Genet"},{"key":"2810_CR198","doi-asserted-by":"publisher","first-page":"779306","DOI":"10.3389\/fnut.2021.779306","volume":"8","author":"X Liu","year":"2021","unstructured":"Liu X et al (2021) Associations of maternal polyunsaturated fatty acids with telomere length in the cord blood and placenta in Chinese population. Front Nutr 8:779306","journal-title":"Front Nutr"},{"issue":"10","key":"2810_CR199","first-page":"CD001059","volume":"10","author":"GJ Hofmeyr","year":"2018","unstructured":"Hofmeyr GJ et al (2018) Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 10(10):CD001059","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"2810_CR200","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1093\/ajcn\/33.10.2202","volume":"33","author":"JM Belizan","year":"1980","unstructured":"Belizan JM, Villar J (1980) The relationship between calcium intake and edema-, proteinuria-, and hypertension-getosis: an hypothesis. Am J Clin Nutr 33(10):2202\u20132210","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"2810_CR201","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0002-9378(83)91049-9","volume":"146","author":"JM Belizan","year":"1983","unstructured":"Belizan JM et al (1983) Preliminary evidence of the effect of calcium supplementation on blood pressure in normal pregnant women. Am J Obstet Gynecol 146(2):175\u2013180","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2810_CR202","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1056\/NEJM199707103370201","volume":"337","author":"RJ Levine","year":"1997","unstructured":"Levine RJ et al (1997) Trial of calcium to prevent preeclampsia. N Engl J Med 337(2):69\u201376","journal-title":"N Engl J Med"},{"issue":"4","key":"2810_CR203","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/0002-9378(88)90091-9","volume":"158","author":"JM Belizan","year":"1988","unstructured":"Belizan JM, Villar J, Repke J (1988) The relationship between calcium intake and pregnancy-induced hypertension: up-to-date evidence. Am J Obstet Gynecol 158(4):898\u2013902","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2810_CR204","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/ajcn\/nqy233","volume":"109","author":"A Cullers","year":"2019","unstructured":"Cullers A et al (2019) Effect of prenatal calcium supplementation on bone during pregnancy and 1 y postpartum. Am J Clin Nutr 109(1):197\u2013206","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"2810_CR205","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3945\/ajcn.2010.29217","volume":"92","author":"LM Jarjou","year":"2010","unstructured":"Jarjou LM et al (2010) Effect of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake. Am J Clin Nutr 92(2):450\u2013457","journal-title":"Am J Clin Nutr"},{"issue":"7103","key":"2810_CR206","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1136\/bmj.315.7103.281","volume":"315","author":"JM Belizan","year":"1997","unstructured":"Belizan JM et al (1997) Long-term effect of calcium supplementation during pregnancy on the blood pressure of offspring: follow up of a randomised controlled trial. BMJ 315(7103):281\u2013285","journal-title":"BMJ"},{"key":"2810_CR207","first-page":"1","volume":"9","author":"S Gunabalasingam","year":"2022","unstructured":"Gunabalasingam S et al (2022) Micronutrient supplementation interventions in preconception and pregnant women at increased risk of developing pre-eclampsia: a systematic review and meta-analysis. Eur J Clin Nutr 9:1\u201321","journal-title":"Eur J Clin Nutr"},{"issue":"1","key":"2810_CR208","doi-asserted-by":"publisher","first-page":"20708","DOI":"10.1038\/s41598-021-00250-5","volume":"11","author":"T Raia-Barjat","year":"2021","unstructured":"Raia-Barjat T et al (2021) Vitamin D deficiency during late pregnancy mediates placenta-associated complications. Sci Rep 11(1):20708","journal-title":"Sci Rep"},{"key":"2810_CR209","doi-asserted-by":"publisher","first-page":"105576","DOI":"10.1016\/j.jsbmb.2019.105576","volume":"199","author":"CL Simner","year":"2020","unstructured":"Simner CL et al (2020) Investigating a suitable model for the study of vitamin D mediated regulation of human placental gene expression. J Steroid Biochem Mol Biol 199:105576","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2810_CR210","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jsbmb.2017.02.003","volume":"173","author":"EV Schulz","year":"2017","unstructured":"Schulz EV et al (2017) Maternal vitamin D sufficiency and reduced placental gene expression in angiogenic biomarkers related to comorbidities of pregnancy. J Steroid Biochem Mol Biol 173:273\u2013279","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"12","key":"2810_CR211","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1055\/s-0042-119040","volume":"48","author":"L Ekstrom","year":"2016","unstructured":"Ekstrom L, Storbjork L, Bjorkhem-Bergman L (2016) Genetic expression profile of vitamin D metabolizing enzymes in the first trimester. Horm Metab Res 48(12):834\u2013839","journal-title":"Horm Metab Res"},{"issue":"7","key":"2810_CR212","first-page":"CD008873","volume":"7","author":"C Palacios","year":"2019","unstructured":"Palacios C, Kostiuk LK, Pena-Rosas JP (2019) Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev 7(7):CD008873","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"2810_CR213","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s003930070034","volume":"59","author":"J Lemire","year":"2000","unstructured":"Lemire J (2000) 1,25-Dihydroxyvitamin D3--a hormone with immunomodulatory properties. Z Rheumatol 59(Suppl 1):24\u201327","journal-title":"Z Rheumatol"},{"issue":"1","key":"2810_CR214","first-page":"10749","volume":"8","author":"N Mohammadi","year":"2020","unstructured":"Mohammadi N et al (2020) Placental calcification and vitamin D Deficiency in low-risk pregnant women. Int J Pediatr 8(1):10749\u201310757","journal-title":"Int J Pediatr"},{"issue":"2","key":"2810_CR215","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3390\/nu13020472","volume":"13","author":"MW Kinshella","year":"2021","unstructured":"Kinshella MW et al (2021) Effects of maternal nutritional supplements and dietary interventions on placental complications: an umbrella review, meta-analysis and evidence map. Nutrients 13(2):472","journal-title":"Nutrients"},{"key":"2810_CR216","doi-asserted-by":"publisher","first-page":"8249264","DOI":"10.1155\/2017\/8249264","volume":"2017","author":"S Behjat Sasan","year":"2017","unstructured":"Behjat Sasan S et al (2017) The effects of vitamin D supplement on prevention of recurrence of preeclampsia in pregnant women with a history of preeclampsia. Obstet Gynecol Int 2017:8249264","journal-title":"Obstet Gynecol Int"},{"issue":"3","key":"2810_CR217","first-page":"1015","volume":"28","author":"N Arain","year":"2015","unstructured":"Arain N, Mirza WA, Aslam M (2015) Review-Vitamin D and the prevention of preeclampsia: A systematic review. Pak J Pharm Sci 28(3):1015\u20131021","journal-title":"Pak J Pharm Sci"},{"key":"2810_CR218","doi-asserted-by":"publisher","first-page":"893848","DOI":"10.3389\/fendo.2022.893848","volume":"13","author":"EA Phillips","year":"2022","unstructured":"Phillips EA et al (2022) Vitamin D supplementation improves mitochondrial function and reduces inflammation in placentae of obese women. Front Endocrinol (Lausanne) 13:893848","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"15","key":"2810_CR219","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.3390\/nu14153008","volume":"14","author":"G Dahma","year":"2022","unstructured":"Dahma G et al (2022) The influence of maternal vitamin D supplementation in pregnancies associated with preeclampsia: a case-control study. Nutrients 14(15):3008","journal-title":"Nutrients"},{"issue":"6","key":"2810_CR220","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.3945\/ajcn.113.072785","volume":"98","author":"Z Asemi","year":"2013","unstructured":"Asemi Z et al (2013) Effects of vitamin D supplementation on glucose metabolism, lipid concentrations, inflammation, and oxidative stress in gestational diabetes: a double-blind randomized controlled clinical trial. Am J Clin Nutr 98(6):1425\u20131432","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"2810_CR221","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1542\/peds.2013-2602","volume":"133","author":"CC Grant","year":"2014","unstructured":"Grant CC et al (2014) Vitamin D during pregnancy and infancy and infant serum 25-hydroxyvitamin D concentration. Pediatrics 133(1):e143\u2013e153","journal-title":"Pediatrics"},{"issue":"9","key":"2810_CR222","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.3390\/jcm11092627","volume":"11","author":"K Jakubiec-Wisniewska","year":"2022","unstructured":"Jakubiec-Wisniewska K, Huras H, Kolak M (2022) Effect of vitamin D supplementation on the cerebral placental ratio in pregnancy complicated with early fetal growth restriction. J Clin Med 11(9):2627","journal-title":"J Clin Med"},{"issue":"1","key":"2810_CR223","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3945\/ajcn.112.037473","volume":"96","author":"SR Crozier","year":"2012","unstructured":"Crozier SR et al (2012) Maternal vitamin D status in pregnancy is associated with adiposity in the offspring: findings from the Southampton Women\u2019s Survey. Am J Clin Nutr 96(1):57\u201363","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"2810_CR224","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1096\/fasebj.7.12.8375611","volume":"7","author":"RC Rose","year":"1993","unstructured":"Rose RC, Bode AM (1993) Biology of free radical scavengers: an evaluation of ascorbate. Faseb J 7(12):1135\u20131142","journal-title":"Faseb J"},{"issue":"1","key":"2810_CR225","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/0002-9378(94)90462-6","volume":"171","author":"MS Mikhail","year":"1994","unstructured":"Mikhail MS et al (1994) Preeclampsia and antioxidant nutrients: decreased plasma levels of reduced ascorbic acid, alpha-tocopherol, and beta-carotene in women with preeclampsia. Am J Obstet Gynecol 171(1):150\u2013157","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2810_CR226","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0301-2115(00)00243-8","volume":"93","author":"S Kharb","year":"2000","unstructured":"Kharb S (2000) Vitamin E and C in preeclampsia. Eur J Obstet Gynecol Reprod Biol 93(1):37\u201339","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"7","key":"2810_CR227","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0143-4004(96)90021-1","volume":"17","author":"AK Poranen","year":"1996","unstructured":"Poranen AK et al (1996) Lipid peroxidation and antioxidants in normal and pre-eclamptic pregnancies. Placenta 17(7):401\u2013405","journal-title":"Placenta"},{"issue":"8","key":"2810_CR228","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1034\/j.1600-0412.2001.080008719.x","volume":"80","author":"RS Bowen","year":"2001","unstructured":"Bowen RS et al (2001) Oxidative stress in pre-eclampsia. Acta Obstet Gynecol Scand 80(8):719\u2013725","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"2810_CR229","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0020-7292(98)00217-3","volume":"64","author":"S Sagol","year":"1999","unstructured":"Sagol S, Ozkinay E, Ozsener S (1999) Impaired antioxidant activity in women with pre-eclampsia. Int J Gynaecol Obstet 64(2):121\u2013127","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"2810_CR230","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1447-0756.2000.tb01343.x","volume":"26","author":"P Panburana","year":"2000","unstructured":"Panburana P, Phuapradit W, Puchaiwatananon O (2000) Antioxidant nutrients and lipid peroxide levels in Thai preeclamptic pregnant women. J Obstet Gynaecol Res 26(5):377\u2013381","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"2810_CR231","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0021-9150(01)00569-X","volume":"158","author":"KD Price","year":"2001","unstructured":"Price KD, Price CS, Reynolds RD (2001) Hyperglycemia-induced ascorbic acid deficiency promotes endothelial dysfunction and the development of atherosclerosis. Atherosclerosis 158(1):1\u201312","journal-title":"Atherosclerosis"},{"issue":"6","key":"2810_CR232","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1471-0528.1997.tb11979.x","volume":"104","author":"AM Gulmezoglu","year":"1997","unstructured":"Gulmezoglu AM, Hofmeyr GJ, Oosthuisen MM (1997) Antioxidants in the treatment of severe pre-eclampsia: an explanatory randomised controlled trial. Br J Obstet Gynaecol 104(6):689\u2013696","journal-title":"Br J Obstet Gynaecol"},{"issue":"9181","key":"2810_CR233","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S0140-6736(99)80010-5","volume":"354","author":"LC Chappell","year":"1999","unstructured":"Chappell LC et al (1999) Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 354(9181):810\u2013816","journal-title":"Lancet"},{"issue":"5","key":"2810_CR234","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.numecd.2019.01.008","volume":"29","author":"H Yusuf","year":"2019","unstructured":"Yusuf H et al (2019) Associations of macro and micronutrients and antioxidants intakes with preeclampsia: a case-control study in Jordanian pregnant women. Nutr Metab Cardiovasc Dis 29(5):458\u2013466","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"6","key":"2810_CR235","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1515\/jpm-2019-0469","volume":"48","author":"N Lorzadeh","year":"2020","unstructured":"Lorzadeh N, Kazemirad Y, Kazemirad N (2020) Investigating the preventive effect of vitamins C and E on preeclampsia in nulliparous pregnant women. J Perinat Med 48(6):625\u2013629","journal-title":"J Perinat Med"},{"issue":"2","key":"2810_CR236","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ajog.2004.09.005","volume":"192","author":"D Beazley","year":"2005","unstructured":"Beazley D et al (2005) Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind, placebo-controlled trial. Am J Obstet Gynecol 192(2):520\u2013521","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2810_CR237","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jfma.2017.08.005","volume":"117","author":"ZM Fu","year":"2018","unstructured":"Fu ZM et al (2018) Vitamins supplementation affects the onset of preeclampsia. J Formos Med Assoc 117(1):6\u201313","journal-title":"J Formos Med Assoc"},{"key":"2810_CR238","doi-asserted-by":"crossref","unstructured":"Man AWC, Li H, Xia N (2020) Resveratrol and the Interaction between gut microbiota and arterial remodelling. Nutrients 12(1)","DOI":"10.3390\/nu12010119"},{"issue":"10","key":"2810_CR239","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.2174\/0929867311320100009","volume":"20","author":"S Bo","year":"2013","unstructured":"Bo S et al (2013) Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial. Curr Med Chem 20(10):1323\u20131331","journal-title":"Curr Med Chem"},{"key":"2810_CR240","doi-asserted-by":"publisher","first-page":"3824509","DOI":"10.1155\/2018\/3824509","volume":"2018","author":"I Peluso","year":"2018","unstructured":"Peluso I et al (2018) Antioxidant, anti-inflammatory, and microbial-modulating activities of nutraceuticals and functional foods 2018. Oxidative Med Cell Longev 2018:3824509","journal-title":"Oxidative Med Cell Longev"},{"key":"2810_CR241","doi-asserted-by":"publisher","first-page":"1390483","DOI":"10.1155\/2018\/1390483","volume":"2018","author":"P Aguilar-Alonso","year":"2018","unstructured":"Aguilar-Alonso P et al (2018) Evaluation of oxidative stress in cardiomyocytes during the aging process in rats treated with resveratrol. Oxidative Med Cell Longev 2018:1390483","journal-title":"Oxidative Med Cell Longev"},{"issue":"2","key":"2810_CR242","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.niox.2011.12.006","volume":"26","author":"H Li","year":"2012","unstructured":"Li H, Xia N, F\u00f6rstermann U (2012) Cardiovascular effects and molecular targets of resveratrol. Nitric Oxide 26(2):102\u2013110","journal-title":"Nitric Oxide"},{"issue":"6","key":"2810_CR243","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrd2060","volume":"5","author":"JA Baur","year":"2006","unstructured":"Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat RevDrug Discov 5(6):493","journal-title":"Nat RevDrug Discov"},{"issue":"1","key":"2810_CR244","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3390\/nu11010143","volume":"11","author":"M Springer","year":"2019","unstructured":"Springer M, Moco S (2019) Resveratrol and its human metabolites\u2014effects on metabolic health and obesity. Nutrients 11(1):143","journal-title":"Nutrients"},{"issue":"9","key":"2810_CR245","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.3390\/ijms20092155","volume":"20","author":"H Li","year":"2019","unstructured":"Li H et al (2019) Resveratrol and vascular function. Int J Mole Sci 20(9):2155","journal-title":"Int J Mole Sci"},{"issue":"3","key":"2810_CR246","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/abbs\/gmu135","volume":"47","author":"C Ma","year":"2015","unstructured":"Ma C et al (2015) Anti-inflammatory effect of resveratrol through the suppression of NF-\u03baB and JAK\/STAT signaling pathways. Acta Biochim Et Biophysica Sinica 47(3):207\u2013213","journal-title":"Acta Biochim Et Biophysica Sinica"},{"key":"2810_CR247","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.phrs.2014.07.006","volume":"89","author":"Y Sun","year":"2014","unstructured":"Sun Y et al (2014) Pharmacological activation of AMPK ameliorates perivascular adipose\/endothelial dysfunction in a manner interdependent on AMPK and SIRT1. Pharmacol Res 89:19\u201328","journal-title":"Pharmacol Res"},{"issue":"8","key":"2810_CR248","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1530\/EC-17-0130","volume":"6","author":"J Ding","year":"2017","unstructured":"Ding J et al (2017) Efficacy of resveratrol to supplement oral nifedipine treatment in pregnancy-induced preeclampsia. Endocr Connect 6(8):595\u2013600","journal-title":"Endocr Connect"},{"issue":"20","key":"2810_CR249","doi-asserted-by":"publisher","first-page":"5063","DOI":"10.1113\/JP278110","volume":"597","author":"JRT Darby","year":"2019","unstructured":"Darby JRT et al (2019) Subcutaneous maternal resveratrol treatment increases uterine artery blood flow in the pregnant ewe and increases fetal but not cardiac growth. J Physiol 597(20):5063\u20135077","journal-title":"J Physiol"},{"issue":"5","key":"2810_CR250","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.placenta.2012.01.012","volume":"33","author":"SL Bourque","year":"2012","unstructured":"Bourque SL et al (2012) Maternal resveratrol treatment during pregnancy improves adverse fetal outcomes in a rat model of severe hypoxia. Placenta 33(5):449\u2013452","journal-title":"Placenta"},{"key":"2810_CR251","doi-asserted-by":"crossref","unstructured":"Bueno-Pereira TO et al (2022) Markers of endothelial dysfunction are attenuated by resveratrol in preeclampsia. Antioxidants (Basel) 11(11)","DOI":"10.3390\/antiox11112111"},{"key":"2810_CR252","doi-asserted-by":"publisher","first-page":"104451","DOI":"10.1016\/j.mvr.2022.104451","volume":"146","author":"J Liu","year":"2022","unstructured":"Liu J, Yao L, Wang Y (2022) Resveratrol alleviates preeclampsia-like symptoms in rats through a mechanism involving the miR-363-3p\/PEDF\/VEGF axis. Microvasc Res 146:104451","journal-title":"Microvasc Res"},{"key":"2810_CR253","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.phrs.2019.04.020","volume":"144","author":"JRT Darby","year":"2019","unstructured":"Darby JRT et al (2019) Systematic review: impact of resveratrol exposure during pregnancy on maternal and fetal outcomes in animal models of human pregnancy complications-Are we ready for the clinic? Pharmacol Res 144:264\u2013278","journal-title":"Pharmacol Res"},{"issue":"16","key":"2810_CR254","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1113\/JP278082","volume":"597","author":"GM Brawerman","year":"2019","unstructured":"Brawerman GM et al (2019) Maternal resveratrol administration protects against gestational diabetes-induced glucose intolerance and islet dysfunction in the rat offspring. J Physiol 597(16):4175\u20134192","journal-title":"J Physiol"},{"key":"2810_CR255","doi-asserted-by":"publisher","first-page":"111511","DOI":"10.1016\/j.exger.2021.111511","volume":"154","author":"DC Castro-Rodriguez","year":"2021","unstructured":"Castro-Rodriguez DC et al (2021) Maternal obesity (MO) programs morphological changes in aged rat offspring small intestine in a sex dependent manner: effects of maternal resveratrol supplementation. Exp Gerontol 154:111511","journal-title":"Exp Gerontol"},{"key":"2810_CR256","doi-asserted-by":"publisher","first-page":"4561083","DOI":"10.1155\/2020\/4561083","volume":"2020","author":"S Viana-Mattioli","year":"2020","unstructured":"Viana-Mattioli S et al (2020) Analysis of SIRT1 expression in plasma and in an in vitro model of preeclampsia. Oxid Med Cell Longev 2020:4561083","journal-title":"Oxid Med Cell Longev"},{"issue":"7","key":"2810_CR257","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1007\/s10815-021-02158-5","volume":"38","author":"Y Huang","year":"2021","unstructured":"Huang Y, Zheng XD, Li H (2021) Protective role of SIRT1-mediated Sonic Hedgehog signaling pathway in the preeclampsia rat models. J Assist Reprod Genet 38(7):1843\u20131851","journal-title":"J Assist Reprod Genet"},{"key":"2810_CR258","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.placenta.2022.04.001","volume":"122","author":"Y Wang","year":"2022","unstructured":"Wang Y et al (2022) SIRT1 regulates trophoblast senescence in premature placental aging in preeclampsia. Placenta 122:56\u201365","journal-title":"Placenta"},{"key":"2810_CR259","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3389\/fphys.2019.01173","volume":"10","author":"AWC Man","year":"2019","unstructured":"Man AWC, Li H, Xia N (2019) The role of Sirtuin1 in regulating endothelial function, arterial remodeling and vascular aging. Front Physiol 10:1173","journal-title":"Front Physiol"},{"key":"2810_CR260","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.ddtec.2012.08.003","volume":"12","author":"W Dang","year":"2014","unstructured":"Dang W (2014) The controversial world of sirtuins. Drug Discov Today: Technol 12:e9\u2013e17","journal-title":"Drug Discov Today: Technol"},{"issue":"1","key":"2810_CR261","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4062\/biomolther.2018.176","volume":"27","author":"JM Pezzuto","year":"2019","unstructured":"Pezzuto JM (2019) Resveratrol: twenty years of growth, development and controversy. Biomole Therap 27(1):1","journal-title":"Biomole Therap"},{"issue":"11","key":"2810_CR262","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.3390\/nu10111651","volume":"10","author":"A Chaplin","year":"2018","unstructured":"Chaplin A, Carp\u00e9n\u00e9 C, Mercader J (2018) Resveratrol, metabolic syndrome, and gut microbiota. Nutrients 10(11):1651","journal-title":"Nutrients"},{"key":"2810_CR263","doi-asserted-by":"publisher","first-page":"104692","DOI":"10.1016\/j.phrs.2020.104692","volume":"155","author":"E Ahmadian","year":"2020","unstructured":"Ahmadian E et al (2020) Pre-Eclampsia: microbiota possibly playing a role. Pharmacol Res 155:104692","journal-title":"Pharmacol Res"},{"key":"2810_CR264","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.preghy.2021.01.002","volume":"23","author":"F Altemani","year":"2021","unstructured":"Altemani F et al (2021) Pregnant women who develop preeclampsia have lower abundance of the butyrate-producer Coprococcus in their gut microbiota. Pregnancy Hypertens 23:211\u2013219","journal-title":"Pregnancy Hypertens"},{"issue":"3","key":"2810_CR265","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1136\/gutjnl-2019-319101","volume":"69","author":"X Chen","year":"2020","unstructured":"Chen X et al (2020) Gut dysbiosis induces the development of pre-eclampsia through bacterial translocation. Gut 69(3):513\u2013522","journal-title":"Gut"}],"container-title":["Pfl\u00fcgers Archiv - European Journal of Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-023-02810-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00424-023-02810-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-023-02810-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T04:39:28Z","timestamp":1729226368000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00424-023-02810-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":265,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["2810"],"URL":"https:\/\/doi.org\/10.1007\/s00424-023-02810-2","relation":{},"ISSN":["0031-6768","1432-2013"],"issn-type":[{"value":"0031-6768","type":"print"},{"value":"1432-2013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,12]]},"assertion":[{"value":"25 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}